Autopsy report · NCT04932915

Safety and Efficacy of Intranasal Administration of Niclosamide (UNI91103) in Adults With Asymptomatic or Mild COVID-19

“Failure of recruiting patients”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 months before it started.
• Ran for about 4 months before it stopped.
• 4 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

UNION therapeutics

Sponsor type

Industry

Conditions

Covid19

Interventions

Niclosamide; Placebo

Participants

4

Sites

3

Countries

Germany

Trials that died the same way

• Resection vs no Resection of the Primary in Colorectal Cancer With Unresectable Metastases
  “Difficulties surrounding recruiting patients” (90% match in meaning)
• Change in Brain Perfusion During Induction of General Anesthesia
  “Difficulties in recruiting patients” (90% match in meaning)
• Metacognitive Therapy for Comorbid Insomnia
  “problems recruiting patients” (89% match in meaning)
• Mechanistic Prehabilitation
  “difficulty in recruiting patients” (88% match in meaning)
• Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Intrathecal Injection for ALS
  “Inability to recruit patients” (87% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.